These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30970005)

  • 41. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance.
    Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G
    Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct prognostic impacts of both atrial volumes on outcomes after radiofrequency ablation of nonvalvular atrial fibrillation: three-dimensional imaging study using multidetector computed tomography.
    Moon J; Lee HJ; Shim J; Uhm JS; Kim JY; Pak HN; Lee MH; Kim YJ; Joung B
    Int J Cardiol; 2013 Oct; 168(6):5430-6. PubMed ID: 24012171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of mitral regurgitation on patients undergoing catheter ablation of atrial fibrillation.
    Gertz ZM; Raina A; Mountantonakis SE; Zado ES; Callans DJ; Marchlinski FE; Keane MG; Silvestry FE
    Europace; 2011 Aug; 13(8):1127-32. PubMed ID: 21490035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Right atrial anatomical remodeling affects early outcomes of nonvalvular atrial fibrillation after radiofrequency ablation.
    Moon J; Hong YJ; Shim J; Hwang HJ; Kim JY; Pak HN; Lee MH; Joung B
    Circ J; 2012; 76(4):860-7. PubMed ID: 22293450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial.
    Doukas G; Samani NJ; Alexiou C; Oc M; Chin DT; Stafford PG; Ng LL; Spyt TJ
    JAMA; 2005 Nov; 294(18):2323-9. PubMed ID: 16278360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Left atrial volume computed by 3D rotational angiography best predicts atrial fibrillation recurrence after circumferential pulmonary vein isolation.
    Strisciuglio T; Di Gioia G; Chatzikyriakou S; Silva Garcia E; Barbato E; Geelen P; De Potter T
    Int J Cardiovasc Imaging; 2018 Mar; 34(3):337-342. PubMed ID: 28918444
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hair ethyl glucuronide concentrations in teetotalers: Should we re-evaluate the lower cut-off?
    Crunelle CL; Yegles M; De Doncker M; Cappelle D; Covaci A; van Nuijs AL; Neels H
    Forensic Sci Int; 2017 May; 274():107-108. PubMed ID: 27884487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Left Atrial Size and Left Ventricular End-Systolic Dimension Predict the Progression of Paroxysmal Atrial Fibrillation After Catheter Ablation.
    Liao YC; Liao JN; Lo LW; Lin YJ; Chang SL; Hu YF; Chao TF; Chung FP; Tuan TC; Te AL; Walia R; Yamada S; Lin CH; Lin CY; Chang YT; Allamsetty S; Yu WC; Huang JL; Wu TJ; Chen SA
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):23-30. PubMed ID: 27779351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.
    Letzner J; Berger F; Schwabe S; Benzing J; Morgenthaler NG; Bucher HU; Bührer C; Arlettaz R; Wellmann S
    Neonatology; 2012; 101(2):116-24. PubMed ID: 21952518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
    Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
    Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.
    Fan J; Cao H; Su L; Ling Z; Liu Z; Lan X; Xu Y; Chen W; Yin Y
    J Interv Card Electrophysiol; 2012 Jan; 33(1):93-100. PubMed ID: 21938519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decrease in B-Type Natriuretic Peptide Levels and Successful Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure.
    Yanagisawa S; Inden Y; Kato H; Fujii A; Mizutani Y; Ito T; Kamikubo Y; Kanzaki Y; Hirai M; Murohara T
    Pacing Clin Electrophysiol; 2016 Mar; 39(3):225-34. PubMed ID: 26596862
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biomarkers and arrhythmia recurrence following radiofrequency ablation of atrial fibrillation.
    Carballo D; Noble S; Carballo S; Stirnemann J; Muller H; Burri H; Vuilleumier N; Talajic M; Tardif JC; Keller PF; Mach F; Shah D
    J Int Med Res; 2018 Dec; 46(12):5183-5194. PubMed ID: 30178684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
    Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
    Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT Trial.
    Truong QA; Siegel E; Karakas M; Januzzi JL; Bamberg F; Mahabadi AA; Dasdemir S; Brady TJ; Bergmann A; Kunde J; Nagurney JT; Hoffmann U; Koenig W
    Clin Chem; 2010 Apr; 56(4):651-60. PubMed ID: 20185624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of diagnostic criteria of heart failure in patients with atrial fibrillation and chronic obstructive pulmonary disease].
    Dzyurich TA; Chesnikova AI; Terentyev VP; Kolomatskaya OE; Safronenko VA
    Kardiologiia; 2019 Sep; 59(10S):4-12. PubMed ID: 31876457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous Closure of Left Atrial Appendage affects Mid-Term Release of MR-proANP.
    Behnes M; Sartorius B; Wenke A; Lang S; Hoffmann U; Fastner C; Borggrefe M; Roth T; Triebel J; Bertsch T; Akin I
    Sci Rep; 2017 Aug; 7(1):9028. PubMed ID: 28831085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure.
    Corell P; Gustafsson F; Kistorp C; Madsen LH; Schou M; Hildebrandt P
    Int J Cardiol; 2007 May; 117(3):395-402. PubMed ID: 16919342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
    Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH
    PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated brain natriuretic peptide level in patients undergoing atrial fibrillation ablation: is it a predictor of failed ablation or a mere function of atrial rhythm and rate at a point in time?
    Pillarisetti J; Reddy N; Biria M; Ryschon K; Nagarajan D; Murray C; Atkins D; Bommana S; Reddy MY; DiBiase L; Pimentel R; Berenbom L; Dawn B; Natale A; Lakkireddy D
    J Interv Card Electrophysiol; 2014 Aug; 40(2):161-8. PubMed ID: 24800931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.